연구동향 분석

REVIEW : Medical Management of Drug-Resistant Tuberculosis

( Doosoo Jeon ) 2015년

논문상세정보
인용/피인용
' REVIEW : Medical Management of Drug-Resistant Tuberculosis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • drug resistance
  • extensivelydrugresistanttuberculosis
  • multidrug resistant
  • tuberculosis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
436 0

0.0%

' REVIEW : Medical Management of Drug-Resistant Tuberculosis' 의 참고문헌

  • WHO group 5 drugs and difficult multidrug-resistant tuberculosis : a systematic review with cohort analysis and meta-analysis
    Chang KC. Antimicrob Agents Chemother 57 : 4097 ~ 4104 [2013]
  • Utility of the REBA MTB-Rifa(R)assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis
    Cho E. BMC Infect Dis 13 : 478 ~ [2013]
  • Trend of anti-tuberculosis drug resistance in Korea, 1994-2004
    Bai GH. Int J Tuberc Lung Dis 11 : 571 ~ 576 [2007]
  • Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first-and second-line drugs : an individual patient data meta-analysis
    Bastos ML. Clin Infect Dis 59 : 1364 ~ 1374 [2014]
  • Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis
    Johnston JC. PLoS One 4 : e6914 ~ [2009]
  • Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis
    Kwon YS. Clin Infect Dis 47 : 496 ~ 502 [2008]
  • Treatment outcomes and prognostic factors in patients with multidrug-resistant tuberculosis in Korean private hospitals
    Park JK. Tuberc Respir Dis 69 : 95 ~ 102 [2010]
  • Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis
    Kim DH. Am J Respir Crit Care Med 178 : 1075 ~ 1082 [2008]
  • Treatment outcomes among patients with multidrug-resistant tuberculosis : systematic review and metaanalysis
    Orenstein EW. Lancet Infect Dis 9 : 153 ~ 161 [2009]
  • Treatment outcomes among patients with extensively drugresistant tuberculosis : systematic review and meta-analysis
    Jacobson KR. Clin Infect Dis 51 : 6 ~ 14 [2010]
  • Treatment of tuberculosis : guidelines for national programmes. 2nd ed
    World Health Organization. World Health Organization [1997]
  • Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector
    전두수 Journal of Korean Medical Science 26 (1) : 33 ~ 41 [2011]
  • The medical and surgical treatment of drug-resistant tuberculosis
    Calligaro GL. J Thorac Dis 6 : 186 ~ 195 [2014]
  • The diarylquinoline TMC207 for multidrug-resistant tuberculosis
    Diacon AH. N Engl J Med 360 : 2397 ~ 2405 [2009]
  • The PIH guide to the medical management of multidrug-resistant tuberculosis. 2nd ed
    Partners In Health. Partners In Health [2014]
  • The National Status of Tuberculosis Using Nationwide Medical Records Survey of Patients with Tuberculosis in Korea
    Yoon-Sung Park Tuberculosis and Respiratory Diseases 73 (1) : 48 ~ 55 [2012]
  • Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis
    Arentz M. PLoS One 8 : e76533 ~ [2013]
  • Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis
    Van Deun A. Am J Respir Crit Care Med 182 : 684 ~ 692 [2010]
  • Selfadministered, standardized regimens for multidrug-resistant tuberculosis in South Korea
    Park SK. Int J Tuberc Lung Dis 8 : 361 ~ 368 [2004]
  • Resistance to fluoroquinolones and second-line injectable drugs : impact on multidrug-resistant TB outcomes
    Falzon D. Eur Respir J 42 : 156 ~ 168 [2013]
  • Rapid molecular TB diagnosis : evidence, policy making and global implementation of Xpert MTB/RIF
    Weyer K. Eur Respir J 42 : 252 ~ 271 [2013]
  • Policy statement. Molecular line probe assay for rapid screening of patients at risk of multidrug-resistant tuberculosis(MDR-TB)
    World Health Organization. World Health Organization [2008]
  • Policy statement. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance : Xpert MTB/RIF system
    World Health Organization. World Health Organization [2011]
  • Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis
    Larsen MH. Mol Microbiol 46 : 453 ~ 466 [2002]
  • Multidrug-resistant tuberculosis and culture conversion with bedaquiline
    Diacon AH. N Engl J Med 371 : 723 ~ 732 [2014]
  • Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients
    Ahuja SD. PLoS Med 9 : e1001300 ~ [2012]
  • Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis : a systematic review and meta-analysis
    Minion J. Lancet Infect Dis 10 : 688 ~ 698 [2010]
  • Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe : a TBNET consensus statement
    Lange C. Eur Respir J 44 : 23 ~ 63 [2014]
  • Linezolid for treatment of chronic extensively drug-resistant tuberculosis
    Lee M. N Engl J Med 367 : 1508 ~ 1518 [2012]
  • Korean guidelines for tuberculosis. 2nd ed. Seoul and
    Joint Committee for the Revision of Korean Guidelines for Tuberculosis. Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korean Centers for Disease Control and Prevention [2014]
  • Increased Tuberculosis Burden Due to Demographic Transition in Korea from 2001 to 2010
    박영길 Tuberculosis and Respiratory Diseases 74 (3) : 104 ~ 110 [2013]
  • Improving outcomes for multidrug-resistant tuberculosis : aggressive regimens prevent treatment failure and death
    Velasquez GE. Clin Infect Dis 59 : 9 ~ 15 [2014]
  • Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR
    Bang H. J Med Microbiol 60 : 1447 ~ 1454 [2011]
  • Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis
    Kim HR. Clin Infect Dis 45 : 1290 ~ 1295 [2007]
  • Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008
    World Health Organization. World Health Organization [2008]
  • Guidelines for the programmatic management of drug-resistant tuberculosis : 2011 update
    World Health Organization. World Health Organization [2011]
  • Guidelines for the programmatic management of drug-resistant tuberculosis
    World Health Organization. World Health Organization [2006]
  • Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis(STREAM) : study protocol for a randomized controlled trial
    Nunn AJ. Trials 15 : 353 ~ [2014]
  • Efficacy, safety and tolerability of linezolid for the treatment of XDRTB : a study in China
    Tang S. Eur Respir J 45 : 161 ~ 170 [2015]
  • Drug resistance beyond extensively drugresistant tuberculosis : individual patient data meta-analysis
    Migliori GB. Eur Respir J 42 : 169 ~ 179 [2013]
  • Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
    Skripconoka V. Eur Respir J 41 : 1393 ~ 1400 [2013]
  • Delamanid for multidrug-resistant pulmonary tuberculosis
    Gler MT. N Engl J Med 366 : 2151 ~ 2160 [2012]
  • Definitions and reporting framework for tuberculosis : 2013 revision
    World Health Organization. World Health Organization [2013]
  • Counting pyrazinamide in regimens for multidrug-resistant tuberculosis
    Franke MF. Ann Am Thorac Soc 12 : 674 ~ 679 [2015]
  • Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis : interim analysis of a French cohort
    Guglielmetti L. Clin Infect Dis 60 : 188 ~ 194 [2015]
  • Comparison of three molecular assays for the detection of rifampin resistance in Mycobacterium tuberculosis
    Moon HW. J Clin Lab Anal 29 : 142 ~ 145 [2015]
  • Comparison of levofloxacin versus moxifloxacin for multidrugresistant tuberculosis
    Koh WJ. Am J Respir Crit Care Med 188 : 858 ~ 864 [2013]
  • Companion handbook to the WHO guidelines for the programmatic management of drugresistant tuberculosis
    World Health Organization. World Health Organization [2014]
  • Clofazimine for the treatment of multidrug-resistant tuberculosis : prospective, multicenter, randomized controlled study in china
    Tang S. Clin Infect Dis 60 : 1361 ~ 1367 [2015]
  • Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
    Caminero JA. Lancet Infect Dis 10 : 621 ~ 629 [2010]
  • American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America : treatment of tuberculosis
    Blumberg HM. Am J Respir Crit Care Med 167 : 603 ~ 662 [2003]
  • Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic
    Kim HJ. Int J Tuberc Lung Dis 5 : 1129 ~ 1136 [2001]
  • Aggressive regimens for multidrugresistant tuberculosis decrease all-cause mortality
    Mitnick CD. PLoS One 8 : e58664 ~ [2013]
  • Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence
    Franke MF. Clin Infect Dis 56 : 770 ~ 776 [2013]
  • 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations : a randomised trial
    Diacon AH. Lancet 380 : 986 ~ 993 [2012]